Skip to main content
. 2014 Jun;6(6):726–733. doi: 10.3978/j.issn.2072-1439.2014.04.08

Table 1. Patients parameters.

Variables VATS (n=38) Open (n=91) P#
Gender (female) 19 (50.00%) 46 (50.55%) 1
Age [years] 50.50 [25-72] 49.63 [15-76] 0.921
BMI* [range] 24.97 [18-34] 25.13 [18-34] 0.444
Symptoms (%)
   Chest pain 9 (23.68) 23 (25.27) 0.036
   Tachypnea 4 (10.53) 12 (13.19) 0.777
   Cough 7 (18.42) 8 (8.79) 0.123
Myasthenia gravis (%) 5 (13.16) 14 (15.38) 0.745
Hypertension (%) 5 (13.16) 11 (12.09) 0.867
Diabetes mellitus (%) 2 (5.26) 0 (0) 0.085
Coronary heart disease (%) 1 (2.63) 1 (1.10) 0.504
Tumor size (cm) 5.4 (2.5-13.0) 6.8 (2.5-13.0) 0.671
Muller-Hermelink classification (%) 0.673
   A 2 (5.26) 7 (7.69)
   B1 7 (18.42) 19 (20.88)
   B2 11 (28.95) 16 (17.58)
   B3 2 (5.26) 9 (9.90)
   AB 16 (42.11) 40 (43.96)
Massaoka staging (%) 0.345
   I 17 (44.74) 49 (53.85)
   II 21 (55.26) 42 (46.15)

*, BMI, body mass index; #, gender, symptoms, myasthenia gravis, hypertension and Massaoka staging were analyzed by Pearson chi-square test. Diabetes mellitus, coronary heart disease and Muller-Hermelink classification were analyzed by Fisher’s exact test. The rest of variables were done by t-test. P≤0.05 was regarded as statistic significance.